Gupta, P. K., Dutta, S., Kala, S., Nekkanti, M., Desai, S. C., Mahapatra, S. S., . . . Udaykumar, K. (2021). Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease. Wiley.
Cita Chicago Style (17a ed.)Gupta, Pawan Kumar, et al. Phase IV Postmarketing Surveillance Study Shows Continued Efficacy and Safety of Stempeucel in Patients with Critical Limb Ischemia Due to Buerger's Disease. Wiley, 2021.
Cita MLA (8a ed.)Gupta, Pawan Kumar, et al. Phase IV Postmarketing Surveillance Study Shows Continued Efficacy and Safety of Stempeucel in Patients with Critical Limb Ischemia Due to Buerger's Disease. Wiley, 2021.
Precaución: Estas citas no son 100% exactas.